Abstract
Plasma free platinum (< 50,000 mol. wt) pharmacokinetics have been studied in eight patients treated with high-dose (800–1600 mg/m 2 ) carboplatin as a 1 h infusion with moderate hydration. Following the infusion levels decayed biphasically with half-lives (x̄ ± S.D.) of 83 ± 15 min and 6.1 ± 2.8 h. The plasma free platinum area under the concentration vs. time curve (AUC) at 1600 mg/m 2 in five patients was 23 ± 2 mg carboplatin/ ml.min. Comparison with data at conventional doses (≤500 mg/m 2 ) gave no indication of non-linear kinetics. Total body clearance of free platinum was found to correlate with glomerular filtration rate ( r = 0.769 P = 0.03), and haematological toxicity white cell nadir and duration of thrombocytopenia correlated with plasma free platinum AUC ( r = 0.784 P = 0.02 and r = 0.885 P = 0.01 respectively). Persistence of platinum was demonstrated in tissues removed at autopsy from a patient who had received carboplatin 14 days earlier. Highest platinum levels were found in the liver kidney skin and small cell lung tumour.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
